| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | ENCODIA INC | 5785 OBERLIN DR | SAN DIEGO | CA | 92121-3749 | SAN DIEGO | USA | R43GM142375 | HT protein profiling with a Next-Gen Protein Assay (NGPA) | 000 | 1 | NIH | 12/5/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = -$224,579 ) |
| | 2023 | 2021 | ENCODIA INC | 5785 OBERLIN DR | SAN DIEGO | CA | 92121-3749 | SAN DIEGO | USA | R44GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing. | 000 | 3 | NIH | 7/20/2023 | $0 |
| | 2023 | 2019 | ENCODIA INC | 5785 OBERLIN DR | SAN DIEGO | CA | 92121-3749 | SAN DIEGO | USA | R43GM134752 | Development of Engineered Trypsin for Proteomics Sample Prep. | 000 | 1 | NIH | 3/14/2023 | -$224,579 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R43GM142375 | HT protein profiling with a Next-Gen Protein Assay (NGPA) | 000 | 1 | NIH | 9/19/2022 | $0 |
| | 2022 | 2021 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44GM123836 | Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing | 000 | 3 | NIH | 9/2/2022 | $0 |
| | 2022 | 2021 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing. | 000 | 3 | NIH | 3/7/2022 | $0 |
| | 2022 | 2019 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 001 | 3 | NIH | 6/1/2022 | $0 |
| | 2022 | 2019 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 3 | NIH | 4/13/2022 | $0 |
| | 2022 | 2019 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R43GM134752 | Development of Engineered Trypsin for Proteomics Sample Prep. | 000 | 1 | NIH | 3/7/2022 | $0 |
| | 2022 | 2018 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R43GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing | 000 | 1 | NIH | 3/1/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,707,821 ) |
| | 2021 | 2021 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R43GM142375 | HT protein profiling with a Next-Gen Protein Assay (NGPA) | 000 | 1 | NIH | 4/23/2021 | $256,182 |
| | 2021 | 2021 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing. | 000 | 3 | NIH | 8/31/2021 | $714,694 |
| | 2021 | 2021 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44GM123836 | Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing | 000 | 3 | NIH | 3/11/2021 | $736,945 |
| | 2021 | 2020 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 3 | NIH | 9/23/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,215,181 ) |
| | 2020 | 2020 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R44GM123836 | Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing | 000 | 2 | NIH | 1/22/2020 | $736,945 |
| | 2020 | 2020 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 3 | NIH | 9/8/2020 | $728,518 |
| | 2020 | 2020 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R44GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing. | 000 | 2 | NIH | 9/9/2020 | $749,718 |
| | 2020 | 2018 | ENCODIA, INC. | 11045 ROSELLE ST STE 120 | SAN DIEGO | CA | 92121-1299 | SAN DIEGO | USA | R43GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing | 000 | 1 | NIH | 9/1/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $956,359 ) |
| | 2019 | 2019 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R44CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 3 | NIH | 8/15/2019 | $731,780 |
| | 2019 | 2019 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R43GM134752 | Development of Engineered Trypsin for Proteomics Sample Prep. | 000 | 1 | NIH | 8/12/2019 | $224,579 |
| | 2019 | 2017 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R43GM123836 | Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing | 000 | 1 | NIH | 1/25/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $941,299 ) |
| | 2018 | 2018 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R44CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 2 | NIH | 9/18/2018 | $718,340 |
| | 2018 | 2018 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R43GM130185 | Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing | 000 | 1 | NIH | 9/13/2018 | $222,959 |
| | 2018 | 2016 | ENCODIA, INC | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R43CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 1 | NIH | 9/11/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $223,600 ) |
| | 2017 | 2017 | PROCURE LIFE SCIENCES, INC. | 11125 FLINTKOTE AVE STE B | SAN DIEGO | CA | 92121-1213 | SAN DIEGO | USA | R43GM123836 | Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing | 000 | 1 | NIH | 8/9/2017 | $223,600 |
|
| Issue Date FY: 2016 ( Subtotal = $211,400 ) |
| | 2016 | 2016 | PROCURE LIFE SCIENCES, INC | 9600 GUDELSKY DR BLDG 1A STE 115 | ROCKVILLE | MD | 20850-3467 | MONTGOMERY | USA | R43CA203629 | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | 000 | 1 | NIH | 9/5/2016 | $211,400 |
|
|
